<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel>
<title>New Food and Drug Administration (FDA) funding opportunities</title>
<link>https://brieflist.pages.dev/grants/funder/food-and-drug-administration-fda/</link>
<description>New Food and Drug Administration (FDA) funding opportunities — Brieflist</description>
<lastBuildDate>Thu, 19 Nov 2026 17:41:39 +0000</lastBuildDate>
<item>
<title>Research on Complex Generics</title>
<link>https://brieflist.pages.dev/grants/g/9179b5a5-research-on-complex-generics/</link>
<guid isPermaLink="false">us-grantsgov:364267</guid>
<pubDate>Mon, 16 Nov 2026 21:21:57 +0000</pubDate>
<description>Food and Drug Administration. Up to $2.5m. Closes 14 Dec 2026. The purpose of this funding opportunity is to expand access for Americans to high-quality, safe, and effective generic medicines, and help reduce the risk of drug shortages through a more competitive and multi-sourced generic drug market in the U.S., …</description>
</item><item>
<title>Flexible Funding Model - Advancing Domestic Mutual Reliance Through Strengthened Infrastructure Development and Maintenance for Manufactured Food Regulatory Programs</title>
<link>https://brieflist.pages.dev/grants/g/a96cdc73-flexible-funding-model-advancing-domestic-mutual-reliance-through-stre/</link>
<guid isPermaLink="false">us-grantsgov:364223</guid>
<pubDate>Mon, 16 Nov 2026 21:21:57 +0000</pubDate>
<description>Food and Drug Administration. Up to $450k. The purpose of this Notice of Funding Opportunity (NOFO) is to advance manufactured food regulatory program infrastructure capacity and capability to achieve and maintain conformance with the Manufactured Food Regulatory Program Standards (MFRPS) and advance …</description>
</item><item>
<title>Development and Maintenance of Human and Animal Food Rapid Response Teams</title>
<link>https://brieflist.pages.dev/grants/g/5f32c11a-development-and-maintenance-of-human-and-animal-food-rapid-response-te/</link>
<guid isPermaLink="false">us-grantsgov:364217</guid>
<pubDate>Mon, 16 Nov 2026 21:21:56 +0000</pubDate>
<description>Food and Drug Administration. Up to $360k. The purpose of this Notice of Funding Opportunity (NOFO) is to develop and maintain Rapid Response Teams (RRTs) to facilitate long-term improvements and innovation within the national integrated food safety system by unifying and coordinating federal, state, …</description>
</item><item>
<title>National Produce Safety Partnership Program</title>
<link>https://brieflist.pages.dev/grants/g/b39843ff-national-produce-safety-partnership-program/</link>
<guid isPermaLink="false">us-grantsgov:364218</guid>
<pubDate>Mon, 16 Nov 2026 21:21:56 +0000</pubDate>
<description>Food and Drug Administration. Up to $12m. This funding opportunity aims to improve the safety of fresh produce and prevent produce-related illnesses.</description>
</item><item>
<title>Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)</title>
<link>https://brieflist.pages.dev/grants/g/1e38963d-reissue-of-rfa-fd-23-001-clinical-studies-of-orphan-products-addressin/</link>
<guid isPermaLink="false">us-grantsgov:360008</guid>
<pubDate>Mon, 16 Nov 2026 21:21:05 +0000</pubDate>
<description>Food and Drug Administration. Up to $900k. Closes 16 May 2028. The purpose of this Notice of Funding Opportunity (NOFO) is to fund clinical trials of products evaluating efficacy and/or safety in support of a new indication or change in labeling to address unmet needs in rare diseases or conditions.</description>
</item><item>
<title>Animal and Veterinary Innovation Centers (U18)</title>
<link>https://brieflist.pages.dev/grants/g/6dba45b7-animal-and-veterinary-innovation-centers-u18/</link>
<guid isPermaLink="false">us-grantsgov:355044</guid>
<pubDate>Mon, 16 Nov 2026 21:21:02 +0000</pubDate>
<description>Food and Drug Administration. Up to $1.2m. Closes 12 May 2028. The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for inclusion as Animal and Veterinary Innovation Centers, which are intended to form long-term partnerships to address priority areas for FDA&#x27;s Center for Veterinary …</description>
</item><item>
<title>Novel approaches to support therapeutic development in ultra-rare cancers</title>
<link>https://brieflist.pages.dev/grants/g/2678231a-novel-approaches-to-support-therapeutic-development-in-ultra-rare-canc/</link>
<guid isPermaLink="false">us-grantsgov:360223</guid>
<pubDate>Mon, 16 Nov 2026 21:20:52 +0000</pubDate>
<description>Food and Drug Administration. Forecast. The purpose of this program is to support new approaches that can be applied to facilitate therapeutic development in ultra-rare pediatric and adult cancers, including molecularly-defined subsets of more common cancers.</description>
</item><item>
<title>Minor Use Minor Species Development of Drugs (R01)</title>
<link>https://brieflist.pages.dev/grants/g/cf5fd8b1-minor-use-minor-species-development-of-drugs-r01/</link>
<guid isPermaLink="false">us-grantsgov:354573</guid>
<pubDate>Mon, 16 Nov 2026 21:20:47 +0000</pubDate>
<description>Food and Drug Administration. Up to $250k. Closes 29 Jan 2027. This Notice of Funding Opportunity (NOFO) is issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), and solicits Research Project (R01) grant applications from institutions or organizations that propose to develop or support …</description>
</item><item>
<title>Retail Food Safety Regulatory Association Collaboration</title>
<link>https://brieflist.pages.dev/grants/g/f48f6865-retail-food-safety-regulatory-association-collaboration/</link>
<guid isPermaLink="false">us-grantsgov:360182</guid>
<pubDate>Mon, 16 Nov 2026 21:20:44 +0000</pubDate>
<description>Food and Drug Administration. $4m in total. Forecast. The program furthers the FDA&#x27;s support of state, local, tribal, and territorial (SLTT) retail food safety programs in their efforts to reduce the occurrence of food-borne illness risk factors for the benefit of the public.</description>
</item><item>
<title>Rapid Response Team (RRT) Cooperative Agreement</title>
<link>https://brieflist.pages.dev/grants/g/3b685985-rapid-response-team-rrt-cooperative-agreement/</link>
<guid isPermaLink="false">us-grantsgov:342810</guid>
<pubDate>Mon, 16 Nov 2026 21:20:43 +0000</pubDate>
<description>Food and Drug Administration. $8.2m in total. Forecast. The purpose of the NOFO is to facilitate long-term improvements and innovation to the national integrated food safety system by unifying and coordinating federal/state/local human and animal food (HAF) emergency response efforts including: 1) Strengthening …</description>
</item><item>
<title>Critical Path Public Private Partnerships Clinical Trials Optional</title>
<link>https://brieflist.pages.dev/grants/g/0e105715-critical-path-public-private-partnerships-clinical-trials-optional/</link>
<guid isPermaLink="false">us-grantsgov:351251</guid>
<pubDate>Mon, 16 Nov 2026 21:20:43 +0000</pubDate>
<description>Food and Drug Administration. Up to $20m. Forecast. The FDA seeks an application to continue to maintain, manage existing consortia groups convened and established by the Critical Path Institute. This is a renewal of the cooperative agreement #5U18FD005320 as part of the Critical Path Initiative.</description>
</item><item>
<title>African Medical Devices Regulatory Harmonization Program</title>
<link>https://brieflist.pages.dev/grants/g/2d3228a7-african-medical-devices-regulatory-harmonization-program/</link>
<guid isPermaLink="false">us-grantsgov:341844</guid>
<pubDate>Mon, 16 Nov 2026 21:20:42 +0000</pubDate>
<description>Food and Drug Administration. Forecast. The purpose of this program is to enable harmonized approaches, standards and guidelines in order to strengthen innovation, development, regulation and availability of medical devices that meet quality and safety requirements in the African continent.</description>
</item><item>
<title>Collaborations to Enhance Drug Development and Regulatory Science</title>
<link>https://brieflist.pages.dev/grants/g/ed1972ab-collaborations-to-enhance-drug-development-and-regulatory-science/</link>
<guid isPermaLink="false">us-grantsgov:351254</guid>
<pubDate>Mon, 16 Nov 2026 21:20:42 +0000</pubDate>
<description>Food and Drug Administration. Up to $5m. Forecast. This Notice of Funding Opportunity (NOFO) invites applications for a cooperative agreement to support, manage and facilitate Public-Private Partnerships and Collaborative activities as part of the Critical Path Initiative and to support regulatory science …</description>
</item><item>
<title>Cooperative Agreement to Support Effective Dissemination of Clinical Practice Guidelines</title>
<link>https://brieflist.pages.dev/grants/g/8042f186-cooperative-agreement-to-support-effective-dissemination-of-clinical-p/</link>
<guid isPermaLink="false">us-grantsgov:356050</guid>
<pubDate>Mon, 16 Nov 2026 21:20:42 +0000</pubDate>
<description>Food and Drug Administration. Up to $1m. Forecast. To support dissemination of clinical practice guidelines, particularly those whose development was previously supported by FDA cooperative agreements.</description>
</item><item>
<title>Flexible Funding Model-Infrastructure Development and Maintenance for State Manufactured Food Regulatory Programs (U2F) Clinical Trials Not Allowed</title>
<link>https://brieflist.pages.dev/grants/g/179e8083-flexible-funding-model-infrastructure-development-and-maintenance-for/</link>
<guid isPermaLink="false">us-grantsgov:351132</guid>
<pubDate>Mon, 16 Nov 2026 21:20:42 +0000</pubDate>
<description>Food and Drug Administration. $340k–$1.3m. Forecast. The intended outcome of this Notice of Funding Opportunity (NOFO) is to advance efforts for a nationally Integrated Food Safety System (IFSS) by supporting Manufactured Food Regulatory Program Standards (MFRPS), Food Protection Task Force (FPTF) programs, …</description>
</item><item>
<title>Integrated Food Safety System Regulatory and Laboratory Training System National Coordination Center</title>
<link>https://brieflist.pages.dev/grants/g/9f0bdf5c-integrated-food-safety-system-regulatory-and-laboratory-training-syste/</link>
<guid isPermaLink="false">us-grantsgov:356045</guid>
<pubDate>Mon, 16 Nov 2026 21:20:42 +0000</pubDate>
<description>Food and Drug Administration. Up to $1.5m. Forecast. The Office of Partnerships (OP) would like to develop a Notice of Funding Opportunity (NOFO) to award a $1.5M cooperative agreement to a non-profit entity to serve as the Integrated Food Safety System (IFSS) Regulatory and Laboratory Training System (RLTS) …</description>
</item><item>
<title>FDA OMHHE Convener for Racial &amp; Ethnic minority Acceleration Consortium for Health Equity (REACH)</title>
<link>https://brieflist.pages.dev/grants/g/6fbb24f8-fda-omhhe-convener-for-racial-ethnic-minority-acceleration-consortium/</link>
<guid isPermaLink="false">us-grantsgov:341723</guid>
<pubDate>Mon, 16 Nov 2026 21:20:41 +0000</pubDate>
<description>Food and Drug Administration. Forecast. The goal of this FOA is to support a convener for FDA OMHHE&#x27;s Racial &amp; Ethnic minority Acceleration Consortium for Health Equity (REACH).</description>
</item><item>
<title>Animal Food Regulatory Program Alliance</title>
<link>https://brieflist.pages.dev/grants/g/3b291870-animal-food-regulatory-program-alliance/</link>
<guid isPermaLink="false">us-grantsgov:356041</guid>
<pubDate>Mon, 16 Nov 2026 21:20:41 +0000</pubDate>
<description>Food and Drug Administration. Up to $600k. Forecast. The goal of FDA/ORA&#x27;s Cooperative Agreement Program is to facilitate long-term improvements to the national food safety system by strengthening interagency collaboration, improving States&#x27; regulatory and surveillance protection programs for manufactured …</description>
</item><item>
<title>Health Equity Innovation Award: Enhance Equity Funding Opportunity (U01) Clinical Trials Not Allowed</title>
<link>https://brieflist.pages.dev/grants/g/ad1c1f17-health-equity-innovation-award-enhance-equity-funding-opportunity-u01/</link>
<guid isPermaLink="false">us-grantsgov:356051</guid>
<pubDate>Mon, 16 Nov 2026 21:20:41 +0000</pubDate>
<description>Food and Drug Administration. Up to $1m. Forecast. The purpose of this notice of funding opportunity (NOFO) is to fund innovative research that will strengthen and advance minority health and health equity objectives.</description>
</item><item>
<title>Identification of Drug-related and Formulation-Related Factors that Result in Alcohol Dose Dumping of Modified Release Oral Drug Products (U01) Clinical Trial Not Allowed</title>
<link>https://brieflist.pages.dev/grants/g/0427cf75-identification-of-drug-related-and-formulation-related-factors-that-re/</link>
<guid isPermaLink="false">us-grantsgov:351128</guid>
<pubDate>Mon, 16 Nov 2026 21:20:41 +0000</pubDate>
<description>Food and Drug Administration. Up to $250k. Forecast. Modified release (MR) oral drug products are considered to have a high risk for alcohol dose dumping (ADD) because they contain large quantities of drug(s), designed to release over a prolonged period of time.</description>
</item><item>
<title>Studies Addressing Rare Neurodegenerative Diseases including ALS</title>
<link>https://brieflist.pages.dev/grants/g/679feedc-studies-addressing-rare-neurodegenerative-diseases-including-als/</link>
<guid isPermaLink="false">us-grantsgov:356046</guid>
<pubDate>Mon, 16 Nov 2026 21:20:41 +0000</pubDate>
<description>Food and Drug Administration. Forecast. The purpose of this funding opportunity announcement (FOA) is to support studies that advance medical product development of interventions intended to prevent, diagnose, mitigate, treat, or cure ALS and other rare neurodegenerative diseases in adults and …</description>
</item><item>
<title>Utilizing Real-World Data and Algorithmic Analyses to Assess Post-Market Clinical Outcomes in Patients Switching Amongst Therapeutically Equivalent Complex Generic Drug Products and Reference Listed Drugs (U01) Clinical Trial Not Allowed</title>
<link>https://brieflist.pages.dev/grants/g/81bf7e72-utilizing-real-world-data-and-algorithmic-analyses-to-assess-post-mark/</link>
<guid isPermaLink="false">us-grantsgov:351125</guid>
<pubDate>Mon, 16 Nov 2026 21:20:41 +0000</pubDate>
<description>Food and Drug Administration. Up to $300k. Forecast. Complex generic drug products represent an increasing share of the generic marketplace and may have distinct user interface differences compared to reference listed drug (RLD) products.</description>
</item><item>
<title>Animal Food Regulatory Program Standards Implementation Development and Maintenance, with Mutual Reliance Initiatives</title>
<link>https://brieflist.pages.dev/grants/g/cdbe57a1-animal-food-regulatory-program-standards-implementation-development-an/</link>
<guid isPermaLink="false">us-grantsgov:356043</guid>
<pubDate>Mon, 16 Nov 2026 21:20:40 +0000</pubDate>
<description>Food and Drug Administration. Up to $10.6m. Forecast. The purpose of this Notice of Funding Opportunity (NOFO) is to advance efforts for a nationally integrated animal food safety system providing State animal food regulatory programs the ability to achieve and maintain full implementation of the Animal Feed …</description>
</item><item>
<title>Clinical Trials Addressing Unmet Needs of Rare Neurodegenerative Diseases (R01) Clinical Trials Required</title>
<link>https://brieflist.pages.dev/grants/g/d19c707e-clinical-trials-addressing-unmet-needs-of-rare-neurodegenerative-disea/</link>
<guid isPermaLink="false">us-grantsgov:356054</guid>
<pubDate>Mon, 16 Nov 2026 21:20:40 +0000</pubDate>
<description>Food and Drug Administration. $650k–$900k. Forecast. The purpose is to fund clinical trials of products evaluating efficacy and/or safety in support of a new indication or change in labeling to address unmet needs in rare neurodegenerative diseases for children and adults.</description>
</item><item>
<title>Cooperative Agreement to Support Activities Related to Analgesics, Anesthetics, and Addiction (U01) Clinical Trials Allowed</title>
<link>https://brieflist.pages.dev/grants/g/a7b54de9-cooperative-agreement-to-support-activities-related-to-analgesics-anes/</link>
<guid isPermaLink="false">us-grantsgov:356049</guid>
<pubDate>Mon, 16 Nov 2026 21:20:40 +0000</pubDate>
<description>Food and Drug Administration. Up to $2m. Forecast. To develop, disseminate, implement, and evaluate research needed in Anesthesia, Addiction Medicine and Pain Medicine in various fields of research.</description>
</item><item>
<title>Cooperative Agreement to Support a Human Abuse Potential Study of Botanical Kratom (U01 Clinical Trial Required)</title>
<link>https://brieflist.pages.dev/grants/g/983bdf86-cooperative-agreement-to-support-a-human-abuse-potential-study-of-bota/</link>
<guid isPermaLink="false">us-grantsgov:351137</guid>
<pubDate>Mon, 16 Nov 2026 21:20:40 +0000</pubDate>
<description>Food and Drug Administration. Up to $2m. Forecast. The U.S. Food and Drug Administration (FDA) seeks applications to develop, implement, and evaluate a human abuse potential (HAP) study of botanical Kratom.</description>
</item><item>
<title>Developing PBPK Model-Based Mechanistic IVIVCs for Long Acting Injectable Suspensions and Implants (U01) Clinical Trial Optional</title>
<link>https://brieflist.pages.dev/grants/g/3b02b987-developing-pbpk-model-based-mechanistic-ivivcs-for-long-acting-injecta/</link>
<guid isPermaLink="false">us-grantsgov:351078</guid>
<pubDate>Mon, 16 Nov 2026 21:20:40 +0000</pubDate>
<description>Food and Drug Administration. Up to $300k. Forecast. The objective of this research proposal is to develop physiologically based pharmacokinetic (PBPK) model-based mechanistic in vitro in vivo correlations (IVIVCs) for two major types of long acting injectables (LAIs) such as crystalline suspensions and …</description>
</item><item>
<title>Development and Maintenance of Human and Animal Food Rapid Response Teams (U2F) Clinical Trials Not Allowed</title>
<link>https://brieflist.pages.dev/grants/g/ae97a315-development-and-maintenance-of-human-and-animal-food-rapid-response-te/</link>
<guid isPermaLink="false">us-grantsgov:351257</guid>
<pubDate>Mon, 16 Nov 2026 21:20:40 +0000</pubDate>
<description>Food and Drug Administration. $360k–$1.4m. Forecast. The purpose of this FOA is to develop and maintain Rapid Response Teams (RRTs) to facilitate long-term improvements and innovation to the national integrated food safety system by unifying and coordinating federal/state/local human and animal food (HAF) …</description>
</item><item>
<title>Retail Food Safety Regulatory Association Collaboration CAP</title>
<link>https://brieflist.pages.dev/grants/g/0d6509cc-retail-food-safety-regulatory-association-collaboration-cap/</link>
<guid isPermaLink="false">us-grantsgov:356048</guid>
<pubDate>Mon, 16 Nov 2026 21:20:40 +0000</pubDate>
<description>Food and Drug Administration. Up to $4m. Forecast. The proposed cooperative agreement is a renewal of the existing CAP supporting key stakeholders in retail food safety to coordinate and advance retail food protection in the United States.</description>
</item><item>
<title>Applied regulatory science research to evaluate and treat cardiotoxicity of oncology therapeutics</title>
<link>https://brieflist.pages.dev/grants/g/8c35d1c6-applied-regulatory-science-research-to-evaluate-and-treat-cardiotoxici/</link>
<guid isPermaLink="false">us-grantsgov:357261</guid>
<pubDate>Mon, 16 Nov 2026 21:20:39 +0000</pubDate>
<description>Food and Drug Administration. Forecast. The goal of this funding opportunity announcement is to support applied regulatory science research to evaluate and treat cardiotoxicity of oncology therapeutics.</description>
</item><item>
<title>Educational Funding Opportunity: Expanding education on skin lightening products (U01) Clinical Trials Not Allowed</title>
<link>https://brieflist.pages.dev/grants/g/823a7dbe-educational-funding-opportunity-expanding-education-on-skin-lightening/</link>
<guid isPermaLink="false">us-grantsgov:356053</guid>
<pubDate>Mon, 16 Nov 2026 21:20:39 +0000</pubDate>
<description>Food and Drug Administration. Up to $250k. Forecast. The purpose of the funding opportunity is to expand and advance FDA&#x27;s Office of Minority Health and Health Equity (OMHHE) work with stakeholders and partners for education, outreach, and public awareness activities on the use of and potential risks from skin …</description>
</item><item>
<title>Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01)</title>
<link>https://brieflist.pages.dev/grants/g/047dede9-identification-and-evaluation-of-possible-approaches-to-addressing-nit/</link>
<guid isPermaLink="false">us-grantsgov:351131</guid>
<pubDate>Mon, 16 Nov 2026 21:20:39 +0000</pubDate>
<description>Food and Drug Administration. Up to $350k. Forecast. The Food and Drug Administration&#x27;s (FDA), Center for Drug Evaluation and Research (CDER), Office of New Drugs (OND), is announcing this Funding Opportunity Announcement (FOA) for a Cooperative Agreement. The proposed work directly supports the U.S.</description>
</item><item>
<title>Integrating Machine Learning with Computational Fluid Dynamics Models of Orally Inhaled Drug Products (U01) Clinical Trials Not Allowed</title>
<link>https://brieflist.pages.dev/grants/g/ca1dcfb2-integrating-machine-learning-with-computational-fluid-dynamics-models/</link>
<guid isPermaLink="false">us-grantsgov:351059</guid>
<pubDate>Mon, 16 Nov 2026 21:20:39 +0000</pubDate>
<description>Food and Drug Administration. $600k in total. Forecast. Computational fluid dynamics (CFD) has played a crucial role in providing an alternative bioequivalence (BE) approach for generic orally inhaled drug products (OIDPs), in addition to comparative clinical endpoint or pharmacodynamic BE studies, as a relatively …</description>
</item><item>
<title>Manufactured Foods Flexible Funding Model (MF-FFM)</title>
<link>https://brieflist.pages.dev/grants/g/b14bd7f7-manufactured-foods-flexible-funding-model-mf-ffm/</link>
<guid isPermaLink="false">us-grantsgov:342630</guid>
<pubDate>Mon, 16 Nov 2026 21:20:39 +0000</pubDate>
<description>Food and Drug Administration. Forecast. The purpose of the NOFO is to advance efforts for a nationally integrated food safety system (IFSS) by supporting Manufactured Food Regulatory Program Standards (MFRPS), dietary supplement safety and oversight programs, improved state compliance and …</description>
</item><item>
<title>OMHHE Educational Funding Opportunity: Expanding education on skin lightening products (U01) Clinical Trials Not Allowed</title>
<link>https://brieflist.pages.dev/grants/g/2ab8664f-omhhe-educational-funding-opportunity-expanding-education-on-skin-ligh/</link>
<guid isPermaLink="false">us-grantsgov:351451</guid>
<pubDate>Mon, 16 Nov 2026 21:20:39 +0000</pubDate>
<description>Food and Drug Administration. Up to $250k. Forecast. The purpose of the funding opportunity is to expand and advance FDA&#x27;s Office of Minority Health and Health Equity (OMHHE) work with stakeholders and partners for education, outreach, and public awareness activities on potential risks from skin lightening …</description>
</item><item>
<title>Cooperative Agreement for Long Term Data Collection on Antimicrobial Use in Animals (U01) Clinical Trial Not Allowed</title>
<link>https://brieflist.pages.dev/grants/g/2119aca2-cooperative-agreement-for-long-term-data-collection-on-antimicrobial-u/</link>
<guid isPermaLink="false">us-grantsgov:351204</guid>
<pubDate>Mon, 16 Nov 2026 21:20:38 +0000</pubDate>
<description>Food and Drug Administration. Up to $200k. Forecast. FDA announces the availability of fiscal year (FY) 2024 funds to support one or more projects to 1) collect antimicrobial use data from diverse animal sectors, including domestic livestock, poultry, companion animals (dogs, cats, and horses), and minor …</description>
</item><item>
<title>Evaluating the Cutaneous Pharmacokinetics of Topical Drug Products Using Pharmacokinetic Tomography (U01 Clinical Trial Required)</title>
<link>https://brieflist.pages.dev/grants/g/0328c56e-evaluating-the-cutaneous-pharmacokinetics-of-topical-drug-products-usi/</link>
<guid isPermaLink="false">us-grantsgov:351126</guid>
<pubDate>Mon, 16 Nov 2026 21:20:38 +0000</pubDate>
<description>Food and Drug Administration. Up to $250k. Forecast. The purpose of this funding opportunity is to support the research and development necessary to advance non-invasive (e.g., quantitative tomography-based) technologies, including the development of apparatus, methods, study designs, and methods of data …</description>
</item><item>
<title>Improving Predictability of Food-Drug and Drug-Drug Interaction Risks by Utilizing In Vitro Simulated Gastrointestinal Dissolution Model for High-Risk Oral Drug Products (U01) Clinical Trial Optional</title>
<link>https://brieflist.pages.dev/grants/g/146a4009-improving-predictability-of-food-drug-and-drug-drug-interaction-risks/</link>
<guid isPermaLink="false">us-grantsgov:351127</guid>
<pubDate>Mon, 16 Nov 2026 21:20:38 +0000</pubDate>
<description>Food and Drug Administration. $250k–$500k. Forecast. The purpose of this funding opportunity is to examine the utility of an in vitro simulated gastrointestinal (GI) dissolution model for the assessment of in vitro performance of amorphous solid dispersion (ASD) drug products under different clinically relevant …</description>
</item><item>
<title>Minor Use Minor Species Development of Drugs (R01)</title>
<link>https://brieflist.pages.dev/grants/g/920811d1-minor-use-minor-species-development-of-drugs-r01/</link>
<guid isPermaLink="false">us-grantsgov:351252</guid>
<pubDate>Mon, 16 Nov 2026 21:20:38 +0000</pubDate>
<description>Food and Drug Administration. Up to $250k. Forecast. This Notice of Funding Opportunity (NOFO) is issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), and solicits Research Project (R01) grant applications from institutions or organizations that propose to develop or support …</description>
</item><item>
<title>FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed)</title>
<link>https://brieflist.pages.dev/grants/g/6bc49b3e-fda-support-for-conferences-and-scientific-meetings-r13-clinical-trial/</link>
<guid isPermaLink="false">us-grantsgov:342752</guid>
<pubDate>Mon, 16 Nov 2026 21:20:37 +0000</pubDate>
<description>Food and Drug Administration. $1m in total. Forecast. The purpose of the FDA (R13) Scientific Conference Grant Program is to facilitate the provision of federal financial assistance in support of high-quality conferences and scientific meetings designed to research and investigate a topic clearly aligned with …</description>
</item><item>
<title>Data Standards for Tobacco Research and Scientific Review Phase 2</title>
<link>https://brieflist.pages.dev/grants/g/ad052720-data-standards-for-tobacco-research-and-scientific-review-phase-2/</link>
<guid isPermaLink="false">us-grantsgov:347925</guid>
<pubDate>Mon, 16 Nov 2026 21:20:37 +0000</pubDate>
<description>Food and Drug Administration. $400k in total. Forecast. To support high-quality tobacco research, streamline scientific review, and evaluation, and ultimately, improve public health outcomes related to tobacco use, the Center for Tobacco Products (CTP) at the Food and Drug Administration (FDA) is welcoming …</description>
</item><item>
<title>Center for Research on Complex Generics (U18) Clinical Trials Optional</title>
<link>https://brieflist.pages.dev/grants/g/dafc6718-center-for-research-on-complex-generics-u18-clinical-trials-optional/</link>
<guid isPermaLink="false">us-grantsgov:356044</guid>
<pubDate>Mon, 16 Nov 2026 21:20:37 +0000</pubDate>
<description>Food and Drug Administration. Up to $1.5m. Forecast. The Food and Drug Administration (FDA) seeks to fund a Center for Research on Complex Generics under the terms and conditions of a cooperative agreement.</description>
</item><item>
<title>FDA OMHHE Health Equity Innovation Award: Enhance Equity Funding Opportunity (U01) Clinical Trials Not Allowed</title>
<link>https://brieflist.pages.dev/grants/g/913f4106-fda-omhhe-health-equity-innovation-award-enhance-equity-funding-opport/</link>
<guid isPermaLink="false">us-grantsgov:351413</guid>
<pubDate>Mon, 16 Nov 2026 21:20:37 +0000</pubDate>
<description>Food and Drug Administration. $250k–$1m. Forecast. The purpose of this funding opportunity announcement (FOA) is to fund innovative research that will strengthen and advance minority health and health equity objectives.</description>
</item><item>
<title>NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens</title>
<link>https://brieflist.pages.dev/grants/g/917adab3-narms-cooperative-agreement-program-to-strengthen-antibiotic-resistanc/</link>
<guid isPermaLink="false">us-grantsgov:356975</guid>
<pubDate>Mon, 16 Nov 2026 21:20:37 +0000</pubDate>
<description>Food and Drug Administration. Up to $4.5m. Forecast. This Funding Opportunity Announcement (FOA) issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), builds upon the National Antimicrobial Resistance Monitoring System (NARMS) which was initiated in 1996 as one of the key …</description>
</item><item>
<title>REACHing Communities (REACH) Consortium (U01) Clinical Trials Optional</title>
<link>https://brieflist.pages.dev/grants/g/3ed4145f-reaching-communities-reach-consortium-u01-clinical-trials-optional/</link>
<guid isPermaLink="false">us-grantsgov:356052</guid>
<pubDate>Mon, 16 Nov 2026 21:20:37 +0000</pubDate>
<description>Food and Drug Administration. Up to $3m. Forecast. This purpose of this notice of funding opportunity (NOFO) is for FDA Office of Minority Health and Health Equity&#x27;s (OMHHE) Health Equity Innovation Award: Racial &amp; Ethnic Minority Acceleration Consortium for Health Equity (REACH).</description>
</item><item>
<title>Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not Allowed</title>
<link>https://brieflist.pages.dev/grants/g/d1e40325-synthesis-and-biological-activity-assessment-of-different-diastereomer/</link>
<guid isPermaLink="false">us-grantsgov:351130</guid>
<pubDate>Mon, 16 Nov 2026 21:20:37 +0000</pubDate>
<description>Food and Drug Administration. Up to $300k. Forecast. The purpose of this research is to systematically evaluate the diastereomeric composition of LEQVIO (Inclisiran), an FDA-approved, N-acetyl galactosamine (GalNAc)-conjugated siRNA drug, and to understand the biological/pharmacological activity of each …</description>
</item><item>
<title>Laboratory Flexible Funding Model (LFFM)</title>
<link>https://brieflist.pages.dev/grants/g/8fefc52c-laboratory-flexible-funding-model-lffm/</link>
<guid isPermaLink="false">us-grantsgov:358411</guid>
<pubDate>Mon, 16 Nov 2026 21:20:32 +0000</pubDate>
<description>Food and Drug Administration. Up to $1.5m. Closes 11 Jan 2028. This cooperative agreement is intended to enhance the capacity and capabilities of state human and animal food testing laboratories in support of an integrated food safety system (IFSS).</description>
</item><item>
<title>Vet-LIRN Capacity-Building Project and Equipment Grants (U18)</title>
<link>https://brieflist.pages.dev/grants/g/320828bc-vet-lirn-capacity-building-project-and-equipment-grants-u18/</link>
<guid isPermaLink="false">us-grantsgov:347990</guid>
<pubDate>Mon, 16 Nov 2026 21:20:29 +0000</pubDate>
<description>Food and Drug Administration. $225k–$2.5m. Closes 4 Sep 2028. The goal of this NOFO is to fund veterinary diagnostic laboratories in the Vet-LIRN network for grants associated with projects and equipment. Specific objectives include: 1.</description>
</item><item>
<title>FDA&#x27;s Integrated Food Safety System Training Delivery and Development</title>
<link>https://brieflist.pages.dev/grants/g/778d081d-fda-s-integrated-food-safety-system-training-delivery-and-development/</link>
<guid isPermaLink="false">us-grantsgov:360091</guid>
<pubDate>Mon, 16 Nov 2026 21:20:29 +0000</pubDate>
<description>Food and Drug Administration. Forecast. The purpose of this funding opportunity is to support the advancement of a nationwide, Integrated Food Safety System (IFSS).</description>
</item><item>
<title>Federal and State Integration Activities to Advance Cooperation and Regulatory Standards Among Animal Food Safety Regulatory Programs</title>
<link>https://brieflist.pages.dev/grants/g/11739685-federal-and-state-integration-activities-to-advance-cooperation-and-re/</link>
<guid isPermaLink="false">us-grantsgov:360094</guid>
<pubDate>Mon, 16 Nov 2026 21:20:29 +0000</pubDate>
<description>Food and Drug Administration. Forecast. The purpose is to provide a funding opportunity for national feed associations to advance and promote a national animal food safety system by building inter-agency collaboration, improving states&#x27; regulatory and surveillance protection programs, and promoting …</description>
</item><item>
<title>Reducing Fraud and Lowering Barriers to the Production of Drugs in Shortage by Outsourcing Facilities</title>
<link>https://brieflist.pages.dev/grants/g/39715a71-reducing-fraud-and-lowering-barriers-to-the-production-of-drugs-in-sho/</link>
<guid isPermaLink="false">us-grantsgov:360095</guid>
<pubDate>Mon, 16 Nov 2026 21:20:29 +0000</pubDate>
<description>Food and Drug Administration. Up to $3m. Forecast. The goals of this grant are to better understand the landscape of drug shortage products, including those vulnerable to health fraud, and identify opportunities for outsourcing facilities to meet drug shortage needs to strengthen the supply chain.</description>
</item><item>
<title>NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens</title>
<link>https://brieflist.pages.dev/grants/g/098a838e-narms-cooperative-agreement-program-to-strengthen-antibiotic-resistanc/</link>
<guid isPermaLink="false">us-grantsgov:360006</guid>
<pubDate>Mon, 16 Nov 2026 21:20:28 +0000</pubDate>
<description>Food and Drug Administration. Up to $200k. Closes 1 Apr 2027. This Funding Opportunity Announcement (FOA) issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), builds upon the National Antimicrobial Resistance Monitoring System (NARMS) which was initiated in 1996 as one of the key …</description>
</item><item>
<title>Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)</title>
<link>https://brieflist.pages.dev/grants/g/fd13391b-reissue-of-rfa-fd-22-001-efficient-and-innovative-natural-history-stud/</link>
<guid isPermaLink="false">us-grantsgov:360007</guid>
<pubDate>Mon, 16 Nov 2026 21:20:28 +0000</pubDate>
<description>Food and Drug Administration. Up to $600k. Closes 8 Feb 2028. The purpose of this notice of funding opportunity (NOFO) is to support efficient and innovative natural history studies that advance medical product development in rare diseases/conditions with unmet needs.</description>
</item><item>
<title>Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)</title>
<link>https://brieflist.pages.dev/grants/g/765f2282-clinical-studies-of-orphan-products-addressing-unmet-needs-of-rare-dis/</link>
<guid isPermaLink="false">us-grantsgov:359987</guid>
<pubDate>Mon, 16 Nov 2026 21:20:28 +0000</pubDate>
<description>Food and Drug Administration. Forecast. The purpose of this opportunity is to fund clinical trials of products evaluating efficacy and/or safety in support of a new indication or change in labeling to address unmet needs in rare diseases or conditions.</description>
</item><item>
<title>Conformance with the Egg Regulatory Program Standards</title>
<link>https://brieflist.pages.dev/grants/g/403426ec-conformance-with-the-egg-regulatory-program-standards/</link>
<guid isPermaLink="false">us-grantsgov:359988</guid>
<pubDate>Mon, 16 Nov 2026 21:20:28 +0000</pubDate>
<description>Food and Drug Administration. Up to $47k. Forecast. The purpose of this funding opportunity is to advance efforts for a nationally integrated food regulatory system by assisting state egg regulatory programs to achieve and maintain full conformance with the Egg Regulatory Program Standards (ERPS).</description>
</item><item>
<title>Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)</title>
<link>https://brieflist.pages.dev/grants/g/8a3fab54-efficient-and-innovative-natural-history-studies-addressing-unmet-need/</link>
<guid isPermaLink="false">us-grantsgov:359985</guid>
<pubDate>Mon, 16 Nov 2026 21:20:28 +0000</pubDate>
<description>Food and Drug Administration. Up to $400k. Forecast. The purpose of this notice of funding opportunity (NOFO) is to support efficient and innovative natural history studies that advance medical product development in rare diseases/conditions with unmet needs.</description>
</item><item>
<title>Food Safety Capacity and Infrastructure Building (U2F)</title>
<link>https://brieflist.pages.dev/grants/g/c496306e-food-safety-capacity-and-infrastructure-building-u2f/</link>
<guid isPermaLink="false">us-grantsgov:359984</guid>
<pubDate>Mon, 16 Nov 2026 21:20:28 +0000</pubDate>
<description>Food and Drug Administration. Up to $1m. Forecast. The purpose of this funding opportunity is to support the development, support, and promotion of innovative information sharing and research tools hosted on the Integrated Food Safety System (IFSS) collaboration/research portal, which serves as a critical …</description>
</item><item>
<title>Animal Food Regulatory Program Standards Implementation Development and Maintenance, with Mutual Reliance Initiatives Clinical Trials Not Allowed</title>
<link>https://brieflist.pages.dev/grants/g/fcd5aa88-animal-food-regulatory-program-standards-implementation-development-an/</link>
<guid isPermaLink="false">us-grantsgov:359816</guid>
<pubDate>Mon, 16 Nov 2026 21:20:27 +0000</pubDate>
<description>Food and Drug Administration. Up to $300k. Closes 1 Apr 2027. The purpose of this Notice of Funding Opportunity (NOFO) is to advance efforts for a nationally integrated animal food safety system providing state animal food regulatory programs the ability to achieve full implementation of the Animal Food Regulatory …</description>
</item>
</channel></rss>
